GDC-3280

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameGDC-3280
Drug Alias NameRG-6069GDC-3280AK-3280AK-3280T
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta inhibitorsLysophosphatidic acid inhibitors
TargetsTransforming growth factor betaLysophosphatidic acid
Therapy Area/IndicationsCicatrix, HypertrophicCicatrixIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGenentech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesGenentech Inc
Active IndicationsCicatrix, HypertrophicCicatrixIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A